These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35843496)

  • 21. Effectiveness of COVID-19 vaccines on hospitalization and death in Guilan, Iran: a test-negative case-control study.
    Heidarzadeh A; Amini Moridani M; Khoshmanesh S; Kazemi S; Hajiaghabozorgi M; Karami M
    Int J Infect Dis; 2023 Mar; 128():212-222. PubMed ID: 36572376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review.
    Das S; Kar SS; Samanta S; Banerjee J; Giri B; Dash SK
    Immunol Res; 2022 Jun; 70(3):289-315. PubMed ID: 35192185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody response after first and second-dose of ChAdOx1-nCOV (Covishield
    Singh AK; Phatak SR; Singh R; Bhattacharjee K; Singh NK; Gupta A; Sharma A
    Vaccine; 2021 Oct; 39(44):6492-6509. PubMed ID: 34600747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of Covishield vaccine in preventing Covid-19 - A test-negative case-control study.
    Pramod S; Govindan D; Ramasubramani P; Kar SS; Aggarwal R;
    Vaccine; 2022 May; 40(24):3294-3297. PubMed ID: 35168838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivated COVID-19 vaccines: durability of Covaxin/BBV152 induced immunity against variants of concern.
    Kumar NP; Banurekha VV; Kumar CPG; Nancy A; Padmapriyadarsini C; Shankar S; Hanna LE; Murhekar M; Devi KRU; Babu S
    J Travel Med; 2022 Sep; 29(6):. PubMed ID: 35900009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 Reinfection Rate and Estimated Effectiveness of the Inactivated Whole Virion Vaccine BBV152 Against Reinfection Among Health Care Workers in New Delhi, India.
    Malhotra S; Mani K; Lodha R; Bakhshi S; Mathur VP; Gupta P; Kedia S; Sankar J; Kumar P; Kumar A; Ahuja V; Sinha S; Guleria R; ; Dua A; Ahmad S; Sathiyamoorthy R; Sharma A; Sakya T; Gaur V; Chaudhary S; Sharma S; Madan D; Gupta A; Virmani S; Gupta A; Yadav N; Sachdeva S; Sharma S; Singh S; Pandey A; Singh M; Jhurani D; Sarkar S; Lokade AK; Mohammad A; Pandit S; Dubey R; Singh AK; Gohar N; Soni D; Bhattacharyya A; Rai S; Tummala S; Gupta I; Shukla S
    JAMA Netw Open; 2022 Jan; 5(1):e2142210. PubMed ID: 34994793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing real-life effectiveness of various COVID-19 vaccine regimens during the delta variant-dominant pandemic: a test-negative case-control study.
    Sritipsukho P; Khawcharoenporn T; Siribumrungwong B; Damronglerd P; Suwantarat N; Satdhabudha A; Chaiyakulsil C; Sinlapamongkolkul P; Tangsathapornpong A; Bunjoungmanee P; Nanthapisal S; Tanprasertkul C; Sritipsukho N; Mingmalairak C; Apisarnthanarak A; Tantiyavarong P
    Emerg Microbes Infect; 2022 Dec; 11(1):585-592. PubMed ID: 35114893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Media Reporting Relating to COVID-19 Vaccination as a Driver of Vaccine Hesitancy Prior to the Second Wave of the COVID-19 Pandemic in India: A Content Analysis of Newspaper and Digital Media Reports.
    Basu S; Sharma H
    Cureus; 2023 Mar; 15(3):e36750. PubMed ID: 37123709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States.
    Schrag SJ; Verani JR; Dixon BE; Page JM; Butterfield KA; Gaglani M; Vazquez-Benitez G; Zerbo O; Natarajan K; Ong TC; Lazariu V; Rao S; Beaver R; Ellington SR; Klein NP; Irving SA; Grannis SJ; Kiduko S; Barron MA; Midturi J; Dickerson M; Lewis N; Stockwell MS; Stenehjem E; Fadel WF; Link-Gelles R; Murthy K; Goddard K; Grisel N; Valvi NR; Fireman B; Arndorfer J; Konatham D; Ball S; Thompson MG; Naleway AL
    JAMA Netw Open; 2022 Sep; 5(9):e2233273. PubMed ID: 36156146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination Can Prevent Severe Pulmonary Disease in COVID-19 Positive Patients: A Case-Control Study.
    Ravichandran S; Vijayakumar K; G V V; P M S
    Cureus; 2023 Sep; 15(9):e45638. PubMed ID: 37868424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of the ChAdOx1 nCoV-19 Coronavirus Vaccine (Covishield
    Murali S; Sakthivel M; Pattabi K; Venkatasamy V; Thangaraj JWV; Shete A; Varghese AJ; Arjun J; Kumar CPG; Yadav PD; Sahay R; Majumdar T; Dudhmal M; Sivalingam A; Dhanapal SR; Durai Samy A; Radhakrishnan V; Muni Krishnaiah MM; Arunachalam S; Gandhi PMK; Govindasamy E; Chinnappan P; Sekar DPV; Marappan P; Pounraj E; Ganeshkumar P; Jagadeesan M; Narnaware M; Bedi GS; Kaur P; Murhekar M
    Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 patients' clinical profile and outcome with respect to their vaccination status: A prospective observational multicentre cohort study during third wave in Western India.
    Patel AK; Patel D; Shevkani M; Shah A; Madan S; Gohel S; Chhatwani C; Doshi A; Patel V; Sukhwani K; Kareliya H; Shah V; Savaj P; Rana M; Patel KK; Bakshi H
    Indian J Med Microbiol; 2023; 41():28-32. PubMed ID: 36870745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary-the HUN-VE study.
    Vokó Z; Kiss Z; Surján G; Surján O; Barcza Z; Pályi B; Formanek-Balku E; Molnár GA; Herczeg R; Gyenesei A; Miseta A; Kollár L; Wittmann I; Müller C; Kásler M
    Clin Microbiol Infect; 2022 Mar; 28(3):398-404. PubMed ID: 34838783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.
    Jara A; Undurraga EA; Zubizarreta JR; González C; Pizarro A; Acevedo J; Leo K; Paredes F; Bralic T; Vergara V; Mosso M; Leon F; Parot I; Leighton P; Suárez P; Rios JC; García-Escorza H; Araos R
    Lancet Glob Health; 2022 Jun; 10(6):e798-e806. PubMed ID: 35472300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reports.
    Sah MK; Singh BM; Sinha P; Devkota P; Yadav SK; Shrestha J; Shrestha A
    J Med Case Rep; 2022 May; 16(1):182. PubMed ID: 35524323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study.
    McKeigue PM; McAllister DA; Hutchinson SJ; Robertson C; Stockton D; Colhoun HM
    Lancet Respir Med; 2022 Jun; 10(6):566-572. PubMed ID: 35227416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A machine learning-based approach to determine infection status in recipients of BBV152 (Covaxin) whole-virion inactivated SARS-CoV-2 vaccine for serological surveys.
    Singh P; Ujjainiya R; Prakash S; Naushin S; Sardana V; Bhatheja N; Singh AP; Barman J; Kumar K; Gayali S; Khan R; Rawat BS; Tallapaka KB; Anumalla M; Lahiri A; Kar S; Bhosale V; Srivastava M; Mugale MN; Pandey CP; Khan S; Katiyar S; Raj D; Ishteyaque S; Khanka S; Rani A; Promila ; Sharma J; Seth A; Dutta M; Saurabh N; Veerapandian M; Venkatachalam G; Bansal D; Gupta D; Halami PM; Peddha MS; Veeranna RP; Pal A; Singh RK; Anandasadagopan SK; Karuppanan P; Rahman SN; Selvakumar G; Venkatesan S; Karmakar MK; Sardana HK; Kothari A; Parihar DS; Thakur A; Saifi A; Gupta N; Singh Y; Reddu R; Gautam R; Mishra A; Mishra A; Gogeri I; Rayasam G; Padwad Y; Patial V; Hallan V; Singh D; Tirpude N; Chakrabarti P; Maity SK; Ganguly D; Sistla R; Balthu NK; A KK; Ranjith S; Kumar BV; Jamwal PS; Wali A; Ahmed S; Chouhan R; Gandhi SG; Sharma N; Rai G; Irshad F; Jamwal VL; Paddar MA; Khan SU; Malik F; Ghosh D; Thakkar G; Barik SK; Tripathi P; Satija YK; Mohanty S; Khan MT; Subudhi U; Sen P; Kumar R; Bhardwaj A; Gupta P; Sharma D; Tuli A; Ray Chaudhuri S; Krishnamurthi S; Prakash L; Rao CV; Singh BN; Chaurasiya A; Chaurasiyar M; Bhadange M; Likhitkar B; Mohite S; Patil Y; Kulkarni M; Joshi R; Pandya V; Mahajan S; Patil A; Samson R; Vare T; Dharne M; Giri A; Mahajan S; Paranjape S; Sastry GN; Kalita J; Phukan T; Manna P; Romi W; Bharali P; Ozah D; Sahu RK; Dutta P; Singh MG; Gogoi G; Tapadar YB; Babu EV; Sukumaran RK; Nair AR; Puthiyamadam A; Valappil PK; Pillai Prasannakumari AV; Chodankar K; Damare S; Agrawal VV; Chaudhary K; Agrawal A; Sengupta S; Dash D
    Comput Biol Med; 2022 Jul; 146():105419. PubMed ID: 35483225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimation of SARS-CoV-2 IgG Antibodies in Healthcare Worker-Administered Covishield and Covaxin Vaccines at a Tertiary Care Hospital in Jharkhand, India.
    Singh B; Seema K; Mahuli AV; Kumar A; Boipai M; Sharma AK; Kumar M; Kumar S; Chandra S; Shahi AK
    Cureus; 2023 Oct; 15(10):e47566. PubMed ID: 38021860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.